Literature DB >> 24424194

Revised diagnostic criteria of multiple sclerosis.

Ron Milo1, Ariel Miller2.   

Abstract

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS) of presumed autoimmune etiology, characterized by localized areas of inflammation, demyelination, axonal loss and gliosis in the brain and spinal cord. Although the clinical presentation and course of the disease are highly variable, several disease types can be recognized, including relapsing-remitting-(RR), primary-progressive-(PP), secondary-progressive-(SP), progressive-relapsing-(PR) MS and clinically-isolated syndrome (CIS). There is no single clinical feature or diagnostic test that is sufficient to diagnose MS, and the diagnosis is mainly a clinical one. Over the years, several sets of criteria have been proposed for the diagnosis of MS, based on the principles of dissemination in space (DIS) and dissemination in time (DIT) of CNS lesions, and the exclusion of other diseases with similar characteristics. With each revision, new diagnostic criteria modified disease definitions and diagnostic thresholds, while aiming at maintaining sensitivity and improving specificity. According to the older Schumacher and Poser criteria, MS can be diagnosed clinically by demonstrating 2 separate attacks (fulfilling DIT criteria) involving at least 2 different areas of the CNS (fulfilling DIS criteria). The 2001 McDonald criteria and their 2005 revision incorporated defined magnetic resonance imaging (MRI) criteria for DIS and DIT that provided guidance on how to diagnose MS after CIS. The most recent 2010 McDonald criteria simplify requirements for DIS and DIT and may allow for an earlier diagnosis of MS from a single baseline brain MRI if there are both silent gadolinium-enhancing and nonenhancing lesions. Despite these important advances in the diagnosis of MS, some questions still remain regarding the application and the implications of the new criteria in the daily clinical practice and in clinical trials. Most importantly, thorough clinical evaluation and judgment along with careful differential diagnosis still remain the basics in the diagnosis of MS.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnosis; Diagnostic criteria; Dissemination in space (DIS); Dissemination in time (DIT); McDonald criteria; Multiple sclerosis (MS)

Mesh:

Year:  2014        PMID: 24424194     DOI: 10.1016/j.autrev.2014.01.012

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  72 in total

1.  The relationship of multiple sclerosis and cerebral developmental venous anomaly with an advantageous role in the multiple sclerosis diagnosis.

Authors:  Mohammad Reza Sasani; Ali Reza Dehghan; Nikseresht Ali Reza
Journal:  Iran J Neurol       Date:  2017-10-07

2.  Association between interleukin-4 and interleukin-10 single nucleotide polymorphisms and multiple sclerosis among Iraqi patients.

Authors:  Milad A Al-Naseri; Ehab D Salman; Ali H Ad'hiah
Journal:  Neurol Sci       Date:  2019-07-01       Impact factor: 3.307

Review 3. 

Authors:  Vincent Wu; Edward A Sykes; Michael M Beyea; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

4.  Optic neuritis caused by the re-emerging great masquerader.

Authors:  Nathanial S Nolan; Laura E Gibbons; Madihah A Hepburn; Ahmed Elkeeb; Hariharan Regunath
Journal:  BMJ Case Rep       Date:  2018-12-22

Review 5.  Cerebrospinal fluid analysis and the determination of oligoclonal bands.

Authors:  Matteo Gastaldi; Elisabetta Zardini; Rosaria Leante; Maddalena Ruggieri; Gianna Costa; Eleonora Cocco; Giovanna De Luca; Ivana Cataldo; Tiziana Biagioli; Clara Ballerini; Massimiliano Castellazzi; Enrico Fainardi; Paola Pettini; Mauro Zaffaroni; Debora Giunti; Elisabetta Capello; Gaetano Bernardi; Emilio Ciusani; Claudia Giannotta; Eduardo Nobile-Orazio; Elena Bazzigaluppi; Gabriella Passerini; Roberta Bedin; Patrizia Sola; Rinaldo Brivio; Guido Cavaletti; Arianna Sala; Antonio Bertolotto; Gaetano Desina; Maurizio A Leone; Sara Mariotto; Sergio Ferrari; Andreina Paternoster; Davide Giavarina; Francesco Lolli; Diego Franciotta
Journal:  Neurol Sci       Date:  2017-10       Impact factor: 3.307

6.  Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.

Authors:  Huanfen Zhou; Shuo Zhao; Dongfang Yin; Xiaofei Chen; Quangang Xu; Tingjun Chen; Xiaoyan Li; Junqing Wang; Hongyang Li; Chunxia Peng; Dahe Lin; Shihui Wei
Journal:  J Neurol       Date:  2016-05-09       Impact factor: 4.849

Review 7.  What Does Optical Coherence Tomography Offer for Evaluating Physical Disability in Patients with Multiple Sclerosis?

Authors:  Ziya Ayhan; Aylin Yaman
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

Review 8.  Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Authors:  Itay Raphael; Johanna Webb; Olaf Stuve; William Haskins; Thomas Forsthuber
Journal:  Expert Rev Clin Immunol       Date:  2014-12-18       Impact factor: 4.473

Review 9.  Autoimmune vertigo: an update on vestibular disorders associated with autoimmune mechanisms.

Authors:  Francesca Yoshie Russo; Massimo Ralli; Daniele De Seta; Patrizia Mancini; Alessandro Lambiase; Marco Artico; Marco de Vincentiis; Antonio Greco
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

10.  Nanopore Fabrication and Application as Biosensors in Neurodegenerative Diseases.

Authors:  Brian Lenhart; Xiaojun Wei; Zehui Zhang; Xiaoqin Wang; Qian Wang; Chang Liu
Journal:  Crit Rev Biomed Eng       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.